Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 479 292
Medical Information e-mail: medicalinformationuk@merck.com

Patient Information Leaflet last updated on the eMC: 23/01/2012
PIL ViraferonPeg Pen 50, 80, 100, 120 or 150 micrograms powder and solvent for solution for injection in pre-filled pen

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 23/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 26/09/2011 and displayed until 23/01/2012
Reasons for adding or updating:
  • Change to Further Information section
  • Change to information about pregnancy or lactation
Updated on 24/08/2011 and displayed until 26/09/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to Marketing Authorisation Holder
Updated on 23/11/2010 and displayed until 24/08/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to instructions about missed dose
  • Change to instructions about overdose
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
Updated on 24/05/2010 and displayed until 23/11/2010
Reasons for adding or updating:
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 29/01/2010 and displayed until 24/05/2010
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
Updated on 27/01/2010 and displayed until 29/01/2010
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   peginterferon alfa-2b